课题基金 / 基金详情

EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease

EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
EAP 衍生单克隆抗体用于疾病动物模型免疫细胞表型分析
批准号:
10933282
负责人:
MARK GEISBERG
金额:
$75.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31

项目摘要

项目成果

MARK GEISBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Silver Lake proposes to fully characterize mAb against 6 targets produced in their three concurrent Phase 1 projects that are relevant in models of disease and inflammation, determine their usability in multiple assay types, develop user protocols for each assay type and mAb, produce quality-controlled reagents, produce multiple conjugates for each mAb, and make all reagents available for the research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers
  • 批准号:
    10053692
  • 项目类别:
  • 资助金额:
    $34.85万
  • 财政年份:
    2020
  • 负责人:
    MARK GEISBERG
  • 依托单位:
EAP-DERIVED MONOCLONAL ANTIBODIES FOR PHENOTYPING GUINEA PIG IMMUNE CELLS.
  • 批准号:
    10291475
  • 项目类别:
  • 资助金额:
    $60.0万
  • 财政年份:
    2020
  • 负责人:
    MARK GEISBERG
  • 依托单位:
Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies
  • 批准号:
    9107441
  • 项目类别:
  • 资助金额:
    $22.01万
  • 财政年份:
    2015
  • 负责人:
    MARK GEISBERG
  • 依托单位:
Rapid LFIA blood test for SCD using highly specific monoclonal antibodies
  • 批准号:
    9170967
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2014
  • 负责人:
    MARK GEISBERG
  • 依托单位:
海外基金